Definitive Contract H9240521C0015
Award Date
9/14/21
Potential Completion Date
7/1/24
Potential Value
$2.1M
Federal Agency
US Special Operations Command
Awardee
Rejuvenate Bio Inc.
Ultimate Awardee
Not listed
PSC Category
AC13 - National Defense R&D Services; Department Of Defense - Military; Experimental Development
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
Rejuvenate Bio Inc., a for-profit small business organization, was awarded a $1,445,046.00 Small Business Innovation Research (SBIR) Phase II contract (SBIR SOCOM182-0002) by the United States Special Operations Command (USSOCOM) to conduct research and prototype development related to neuroenhancement and human performance optimization technologies for special operations forces. The contract, which is a definitive cost-plus-fixed-fee contract, was designated as a total small business...
This federal contract was awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, for SBIR Phase II research and prototype development related to neuroenhancement and human performance optimization technologies. The $1,975,972.00 cost-plus-fixed-fee contract was designated as a total small business set-aside. Rejuvenate Bio Inc. has previously received other SBIR Phase I, II, and II plus prototype development awards from USSOCOM,...
Rejuvenate Bio Inc., a for-profit small business, was awarded a $2,220,133.00 cost-plus-fixed-fee contract by the United States Special Operations Command (USSOCOM) to conduct Small Business Technology Transfer (STTR) Phase II research and prototype development related to neuroenhancement and human performance optimization technologies. The award, which was designated as a total small business set-aside, supports Rejuvenate Bio's ongoing research initiatives aimed at enhancing the capabilities...
This contract was awarded by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a for-profit small business, to conduct a feasibility study under the Small Business Innovation Research (SBIR) Phase I program. The contract, valued at $149,991.00, is for research related to the topic of "Improving Human Performance Through Neuroenhancement" and has a completion date of May 9, 2019. The contract was designated as a total small business set-aside and is a...
This federal contract award, identified as H9240522C0005, was issued by the United States Special Operations Command (USSOCOM) to Rejuvenate Bio Inc., a small business, for the SBIR Phase II topic 182-002 "Neuroenhancement". The cost-plus-fixed-fee contract has a ceiling value of $2,992,731.00 and a final completion date of December 16, 2024. The contract was set aside for small businesses and involves research and prototype development services related to neuroenhancement and human...
The United States Special Operations Command (USSOCOM) awarded a Small Business Technology Transfer (STTR) Phase I contract to Rejuvenate Bio Inc., a for-profit small business, to conduct a feasibility study on human performance optimization technologies. The $149,903.88 firm-fixed-price contract was set aside for total small business participation. Rejuvenate Bio Inc. will perform the research and prototype development work in Brookline, MA. This STTR Phase I contract is part of a larger...
This is a firm fixed-price purchase order contract awarded by the United States Special Operations Command (USSOCOM) to Apollo Neuroscience, Inc., a self-certified small disadvantaged, woman-owned small business. The $149,823.60 contract is for a Phase I Small Business Innovation Research (SBIR) feasibility study under Topic SOCOM182-002, "Improving Human Performance through Neuroenhancement". The study is to be performed in Pittsburgh, PA and was awarded on November 7, 2018 with a...
This is a $2,266,107.00 fixed-price cost-plus-fixed-fee contract awarded by the United States Special Operations Command (USSOCOM) to Surany Research And Development LLC, a small business contractor. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program and is focused on research and development related to the coronavirus (COVID-19) pandemic. The contract has a period of performance through March 31, 2022. Surany Research And Development LLC has previously...
This is a $8,340,352.00 Other Transaction Agreement awarded by the U.S. Special Operations Command (USSOCOM) to Liberty Biosecurity LLC, a self-certified small disadvantaged business. The contract is for pre-clinical and Phase IIA human performance trial work, with a period of performance ending on February 28, 2026. The contract does not have a set-aside designation. Based on the agency, the work is likely supporting USSOCOM's research and development efforts related to human performance...
<p>This is a $1,820,584.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the United States Special Operations Command (USSOCOM) to Research Logistics Company, a small disadvantaged, woman-owned limited liability company. The contract, awarded on July 1, 2019, is for research and prototype development related to STTR (Small Business Technology Transfer) topic and logistics. The definitive, cost-plus-fixed-fee contract has a completion date of January 4, 2024.</p>